# Pyolysin

## Facts

| | |
|---|---|
| Origin | Germany |
| Headquarters | Bernburg (Saale) |
| Owner | Serumwerk Bernburg AG |
| Status | Active |
| Manufacturing | Bernburg (Saale), Germany |
| Distribution | Pharmacy |
| Website | https://pyolysin-salbe.de/ |

Pyolysin is a German brand of wound-and-healing ointment made by the pharmaceutical company Serumwerk Bernburg AG in Bernburg (Saale). Its single product, Pyolysin Wund- und Heilsalbe (wound and healing ointment), is a non-prescription medicine rather than a cosmetic, and it is sold through pharmacies [8]. The brand is a survivor of the East German economy: German Wikipedia's list of brand names from the German Democratic Republic (GDR) includes it, describing it as an anti-inflammatory and antiseptic wound ointment [6].

The brand remains active. Its manufacturer still lists the ointment among its pharmacy products, and the brand's own one-page website carried updated materials in early 2025. Trade press has described Pyolysin as a name known mainly in the eastern German states, where it shares that regional recognition with Serumwerk's other long-running pharmacy brands [7].

## History & milestones

When the brand itself was created is not clearly documented, and the available sources point in slightly different directions. German Wikipedia records Pyolysin as manufactured by Serumwerk Bernburg since 1954 [6]. That date matches the founding of the factory rather than, necessarily, the founding of the brand. Serumwerk's own company history explains that a decision by the GDR Council of Ministers converted the existing Serum-Werk Dessau into a vaccine research institute and moved its production to a new, independent plant in Bernburg [3]. The ointment may therefore be older than the Bernburg factory and may have arrived with the production transferred from Dessau. The brand's website, for its part, speaks only of more than 60 years, without naming a starting year. This article treats 1954 as the start of manufacture in Bernburg, not as a confirmed founding year.

According to Serumwerk, the foundation stone of the state-owned VEB Serumwerk Bernburg was laid on 1 January 1954, on the grounds of the former Weigel chocolate factory. Over the following years the plant built up three lines of production: infusion solutions for hospitals, medicines for pharmacies and veterinary drugs. Pyolysin belonged to the second of these, the pharmacy range that reached ordinary households.

The company grew steadily through the GDR decades. In the 1960s much of its effort went into dextran, a sugar-derived compound used in infusion solutions, and in 1961 it launched an iron product for piglets. By the 1970s, the company says, more than 200 different medicines, health-care products and laboratory chemicals had been developed in Bernburg since 1954, and by the end of that decade the plant produced around 90 percent of the veterinary medicines needed in the GDR. In the early 1980s, sites in Leipzig and Dresden were merged into the business, and by 1988 the workforce had reached 686.

The political change of November 1989 reshaped the company's situation, as it did for most East German industry. Serumwerk Bernburg was privatised as a public limited company (Aktiengesellschaft) through a management buy-out at the end of February 1992 [3]. Pyolysin passed into the new company along with the rest of the pharmacy range.

In later years the brand's fortunes were tied to how Serumwerk chose to sell its consumer products. A 2019 report by the German pharmacy trade publication APOTHEKE ADHOC, written with the news agency dpa, describes how Serumwerk ended a sales partnership with the consumer-goods company Queisser in the summer of 2014 [7]. After that, four of Serumwerk's own field representatives promoted Pulmotin, Pyolysin and Parodontal to pharmacies. A further sales partnership with a company called Doublehill had been planned but, according to the same report, apparently never came about. The article's focus was a push to make the cold ointment Pulmotin better known in western Germany, which underlines how strongly the company's pharmacy brands, Pyolysin included, remained rooted in the east.

## Ownership

Pyolysin is owned and produced by Serumwerk Bernburg AG, which is named as the publisher of the brand's website and has its registered seat in Bernburg [2]. No sale or transfer of the brand to another owner is documented; it has stayed with the same manufacturer from the GDR era through privatisation to the present.

Serumwerk itself is a mid-sized pharmaceutical group. It describes itself as having grown into an internationally recognised producer and supplier of medicines and medical devices for human and veterinary medicine [5]. The group includes Serumwerk Bernburg Vertriebs GmbH, which handles sales of dialysis products and eye-rinse solutions; MTP Medical Technologies GmbH, which makes medical technology and medical devices; and an animal-health department that sells veterinary drugs. According to the 2019 trade report, the company also produces infusion solutions and concentrates for hospitals and was then expanding its dialysis rinse solutions and its iron products for animals. Its chief executive at the time, Frank Kilian, said the company was aiming for revenue of about 73 million euros that year, five million more than the year before [7].

Within this group, Pyolysin is a small part of a wider business that is focused mainly on hospital, dialysis and veterinary products. It sits in the pharmacy range next to brands such as Pulmotin and Parodontal.

## Philosophy & positioning

Pyolysin presents itself as a first-aid product for everyday wounds. Its website calls it "first aid for wounds" and uses the line "Gehört in jede Hausapotheke", meaning that it belongs in every home medicine cabinet. The positioning is practical and medical rather than cosmetic; there is no beauty or lifestyle framing.

The brand's reasoning about wound care is set out at some length on its website. Once bleeding has stopped, the site explains, a normal inflammatory reaction follows, and this reaction helps keep the immune response going and starts the healing process. If germs enter the wound, infection can disturb that process. From this, the company argues that a good wound remedy should not only reduce the number of germs in a wound but also support the healing itself, especially during the inflammatory phase [1].

Pyolysin describes its formula as a combination of natural active substances and long-established medicinal substances. The company stresses one point in particular: although the ointment is said to act against microbes, it is not a classic antibiotic. The website repeats this distinction several times, which sets the product apart, in its own telling, from antibiotic wound creams.

The brand's own materials also lean on its origin. The website carries the line "Pharmazeutische Vielfalt Made In Germany" (pharmaceutical diversity made in Germany), a company-level statement from Serumwerk that applies to the whole range.

## Products & innovation

The range consists of one product, Pyolysin Wund- und Heilsalbe, offered in several tube sizes. A drug database that reproduces the German package leaflet lists it as a non-prescription cream from Serumwerk Bernburg AG, classed among emollients and skin-protective agents. The company calls the ointment one of a kind and claims what it describes as a threefold action. According to the brand, it strengthens the body's own defences in the wound area and moderates the inflammatory reaction; it acts against microbes and so slows the growth of germs in the wound; and it supports wound closure and fast healing.

These are the company's own claims about how the product works, not findings from clinical trials. The approved use is worded with care. The ointment is indicated for superficial wounds, for example as a supplementary treatment for ulcers on the lower leg, and that indication is stated to rest on experience rather than on trial evidence [1]. The product is to be applied two to three times a day in a thin layer.

The only registered clinical study of the ointment shows how little formal trial data exists. Serumwerk Bernburg sponsored an open study, registered in the EU Clinical Trials Register under EudraCT number 2011-002755-34, to confirm how well children aged 0 to 17 tolerate the ointment when it is used on superficial wounds [9]. The study ran at a single centre in Germany between March 2012 and November 2014. It was ended early after only 3 of the 120 planned patients had been recruited. No adverse events were observed in those three children, and the results were published on 15 May 2016. With so few participants, the study could not show whether the ointment is effective, and it was not designed to.

No third-party certifications are documented for the product, and no patents or research partnerships connected to it are publicly described.

## Current status

Pyolysin is an active brand. Its website, run by Serumwerk Bernburg AG, carried an updated package leaflet and new product images in early 2025, and as of November 2026 it points buyers to several online pharmacies as well as to local pharmacies. Serumwerk's corporate website also continues to list the ointment among its pharmacy products [4].

The brand's reach appears to be largely confined to Germany. Its website is in German only, its product is approved in Germany, and the 2019 trade report described it as known chiefly in the eastern part of the country. The brand has no documented social media presence.

## Timeline {#belagg-timeline}

| Year | Event | Source |
|---|---|---|
| 1954 | Parent company: foundation stone of VEB Serumwerk Bernburg laid on 01.01.1954 on the site of the former Weigel chocolate factory, after a GDR Council of Ministers decision moved the existing production of Serum-Werk Dessau to Bernburg. | https://serumwerk.com/unternehmen/historie/ |
| 1954 | German Wikipedia's list of GDR brand names records Pyolysin as manufactured by Serumwerk Bernburg since 1954 ('seit 1954 in der Herstellung durch das Serumwerk Bernburg'). Whether the brand itself is older is not stated. | https://de.wikipedia.org/wiki/Liste_von_Markennamen_und_Produkten_in_der_DDR |
| 1992 | Parent company Serumwerk Bernburg privatized as an Aktiengesellschaft through a management buy-out at the end of February 1992. | https://serumwerk.com/unternehmen/historie/ |
| 2014 | Serumwerk ended its sales cooperation with Queisser in summer 2014; afterwards four in-house field representatives promoted Pulmotin, Pyolysin and Parodontal. | https://www.apotheke-adhoc.de/nachrichten/detail/markt/serumwerk-west-offensive-fuer-pulmotin-pharmahersteller/ |
| 2014 | EU-registered open study (EudraCT 2011-002755-34), sponsored by Serumwerk Bernburg, on the tolerability of Pyolysin-Salbe in children aged 0-17 with superficial wounds: recruitment 01 Mar 2012 to 03 Nov 2014 at one centre in Germany; only 3 of 120 planned patients recruited; no adverse events observed; results published 15 May 2016. | https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002755-34/results |

## Signature products {#belagg-products}

- **Pyolysin® Wund- und Heilsalbe** — Das Unikat! Pyolysin® Wund- und Heilsalbe enthält mit ihrer Kombination aus natürlichen Wirkstoffen und altbewährten Arzneistoffen eine für die Wundheilung optimale Zusammensetzung. — https://pyolysin-salbe.de/

## Key ingredients {#belagg-ingredients}

Pyolysin-Kulturfiltrat · Zinkoxid · Salicylsäure

Source: https://medikamio.com/de-de/medikamente/pyolysin-salbe/pil

## Mentioned in {#belagg-press}

- **APOTHEKE ADHOC (with dpa)** (2019) — Article on Serumwerk Bernburg's plan to sell Pulmotin more widely in western Germany; states that Pulmotin, Pyolysin and Parodontal are known mainly in the eastern German states ('die vor allem in den neuen Bundesländer bekannt sind'). — https://www.apotheke-adhoc.de/nachrichten/detail/markt/serumwerk-west-offensive-fuer-pulmotin-pharmahersteller/

## Sources

1. (T1) https://pyolysin-salbe.de/
2. (T2) https://pyolysin-salbe.de/impressum/
3. (T2) https://serumwerk.com/unternehmen/historie/
4. (T2) https://serumwerk.com/produkte/apothekenprodukte/
5. (T2) https://serumwerk.com/unternehmen/unternehmensgruppe/
6. (T3) https://de.wikipedia.org/wiki/Liste_von_Markennamen_und_Produkten_in_der_DDR
7. (T3) https://www.apotheke-adhoc.de/nachrichten/detail/markt/serumwerk-west-offensive-fuer-pulmotin-pharmahersteller/
8. (T4) https://medikamio.com/de-de/medikamente/pyolysin-salbe/pil
9. (T4) https://www.clinicaltrialsregister.eu/ctr-search/trial/2011-002755-34/results

---

Glowpedia · <https://glowpedia.org/m/pyolysin/> · Published 2026-11-15

Please cite with a link to the article URL.
